Morphologic and molecular analysis of early‐onset gastric cancer. Issue 1 (13th October 2020)

• Record Type: Journal Article
• Authors: Setia, Namrata; Wang, Cindy X.; Lager, Angela; Maron, Steve; Shroff, Stuti; Arndt, Nicole; Peterson, Bryan; Kupfer, Sonia S.; Ma, Changqing; Misdraji, Joseph; Catenacci, Daniel; Hart, John
• Is Part Of: Cancer. Volume 127:Issue 1(2021)
• Page Start: 103
• Page End: 114
• Publication Date: 2020-10-13
• Subjects: early onset -- gastric -- molecular -- morphologic; Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.33213
• Languages: English
• ISSNs: 0008-543X

Abstract

Abstract : Background: Evidence suggests that early‐onset gastric cancers are distinct from traditional gastric cancers; however, detailed genomic and morphologic characterization of these cancers has not been performed. Methods: Genomic analysis was performed for 81 patients with gastric cancer who were 50 years old or younger; pathology slides were available for 53 of these patients, and they were re‐reviewed to perform a morphologic‐molecular correlation analysis. The results were compared with corresponding cBioPortal data and The Cancer Genome Atlas (TCGA) analysis, which represent traditional gastric cancers. The TP53 molecular signature was established to determine the pattern of somatic mutational damage. Variants of potential germline origin were also identified from next‐generation sequencing data. Results: A higher rate of CDH1 mutations (22.2% of early‐onset gastric cancers vs 11.4% of traditional gastric cancers; P = .0042) but a similar rate of TP53 mutations (63% of early‐onset gastric cancers vs 56.6% of traditional gastric cancers; P = .2674) were seen in early‐onset cancers in comparison with traditional gastric cancers. The diffuse/mixed types correlated with the TCGA genomically stable type, and the remaining Lauren types correlated with the TCGA chromosomal instability type. Diffuse and indeterminate histologic types (overall survival, 26.25 months for the intestinal type, 20.5 months for the mixed type, 12.62 months for the diffuse type, and 9 months for the indeterminate type; P = .027) and the presence of a CDH1 gene mutation (overall survival, 9 months for mutant CDH1 and 22 months for wild‐type CDH1 ; P = .013) significantly correlated with worse survival. The TP53 gene frequently showed transition mutations (65.5%) involving the CpG sites (49%). Variants of potential germline origin were seen in high‐penetrance genes ( CDH1 and APC ) and moderate‐penetrance genes ( ATM, NBN, and MUTYH ) in 9.9% of cancers. Conclusions: Early‐onset gastric cancer has distinct genomic alterations, such as CDH1 mutations, but shares with traditional gastric cancers a high frequency of TP53 mutations and the TP53 mutagenic signature. Diffuse and indeterminate histologic types and the presence of a CDH1 mutation are associated with worse overall survival. Endogenous factors leading to cytosine deamination and potential germline alterations in moderate‐penetrance cancer susceptibility genes may be implicated in the pathogenesis of these cancers. Abstract : Early‐onset gastric cancers have distinct genomic alterations, such as CDH1 mutations, but share with traditional gastric cancers a high frequency of TP53 mutations and the TP53 mutagenic signature. The histologic classification and the CDH1 mutation status correlate with overall survival. Endogenous factors leading to cytosine deamination and potential germline alterations in moderate‐penetrance cancer susceptibility genes may be implicated in the pathogenesis of these cancers.